Back to top

Zacks.com Most Recent Articles

Zacks Equity Research

AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China

Analyst Blog

AstraZeneca's (AZN) roxadustat gets a second marketing approval in China for treating anaemia caused by chronic kidney disease in non-dialysis-dependent patients.

LLY MRK AZN FGEN

Zacks Equity Research

AeroVironment (AVAV) Dips More Than Broader Markets: What You Should Know

Tale of the Tape

AeroVironment (AVAV) closed the most recent trading day at $52.78, moving -0.51% from the previous trading session.

AVAV

Sejuti Banerjea

Target and 3 Other Retail Stocks to Buy Today

Analyst Blog

The retail sector looks attractive given growing evidence of consumer confidence holding up well.

GPI TGT IMKTA CNXN

Zacks Equity Research

Novo Nordisk's Fiasp Gets EC Approval for Label Expansion

Analyst Blog

Novo Nordisk (NVO) receives EC approval for its fast-acting insulin aspart, Fiasp, for the treatment of diabetes in adolescents and children aged one year or older.

NVS RHHBY NVO GILD

Zacks Equity Research

Alibaba, Dillard's, Coca-Cola, McDonald's and Comcast highlighted as Zacks Bull and Bear of the Day

Press Releases

Alibaba, Dillard's, Coca-Cola, McDonald's and Comcast highlighted as Zacks Bull and Bear of the Day

BABA KO CMCSA MCD DDS

Zacks Equity Research

Mastercard Simplifies Payments at Miami Metrorail Stations

Analyst Blog

Mastercard (MA) teams up with Cubic Transportation Systems and Miami-Dade County Department of Transportation and Public Works to unveil tap-and-go payments at Miami Metrorail stations.

CATM PYPL MA V

Zacks Equity Research

MyoKardia Begins Dosing in Phase I Study on Heart Candidate

Analyst Blog

MyoKardia (MYOK) doses the first patient in phase I study on MYK-224, which is being evaluated for treating patients with hypertrophic cardiomyopathy, a common heart disease.

MYOK CGEN ALDR ALXN

Zacks Equity Research

Forum Energy (FET) Announces Stake Sale in Ashtead Technology

Analyst Blog

With the sale of its 40% stake in Ashtead Technology, Forum Energy (FET) will receive $39 million of cash proceeds alongside an $8.5-million loan with a three-year maturity period.

DRQ FET INT ENB

Zacks Equity Research

Ensign Group (ENSG) Up 33.2% in a Year: More Room for Rally?

Analyst Blog

Ensign Group's (ENSG) revenue stream and strategic initiatives should bolster revenue growth. This will likely support its share price going forward.

CNC MOH ANTM ENSG

Zacks Equity Research

CSX Gets Mired in Headwinds: Discard the Stock Right Now

Analyst Blog

Sluggish intermodal volumes among other factors force CSX to slash its 2019 revenue growth forecast.

CPA DAL GATX CSX

Zacks Equity Research

Abbott's Libre Adoption a Positive, Rhythm Management a Woe

Analyst Blog

Abbott (ABT) is steadily riding high on a healthy growth track within its Diabetes Care business.

ABT BAX NUVA MDT

Zacks Equity Research

Zimmer Biomet Wins Nod for Spinal Teather to Treat Scoliosis

Analyst Blog

Zimmer Biomet's (ZBH) AVBT solution, The Tether, uses a solid, flexible cord in place of traditional metal rods to pull on the outside of a scoliosis curve.

BAX MDT NUVA ZBH

Zacks Equity Research

Union Pacific Stock Up 22% YTD on Cost Cut & Other Factors

Analyst Blog

Union Pacific's (UNP) cost-controlling measures are driving growth. Additionally, the company's efforts to reward shareholders are appreciative.

DAL CPA GATX UNP

Zacks Equity Research

Synopsys (SNPS) Beats on Q3 Earnings, Raises FY19 Guidance

Analyst Blog

Synopsys' (SNPS) third-quarter fiscal 2019 results benefit from growing demand for its strong product portfolio.

PRFT LOGM SNPS AXE

Zacks Equity Research

Hawaiian Holdings at 52-Week Low: Does It Still Hold Promise?

Analyst Blog

Hawaiian Holdings (HA) is suffering due to intense competition following Southwest Airlines' entry in Hawaii. However, its history with respect to punctuality raises optimism.

LUV DAL CPA HA

Zacks Equity Research

BeiGene's NDA for Zanubrutinib Gets Priority Review From FDA

Analyst Blog

The FDA grants priority review to BeiGene's (BGNE) NDA seeking approval for zanubrutinib as a treatment for mantle cell lymphoma.

RHHBY BGNE CELG TEVA

Zacks Equity Research

Hasbro (HAS) Outruns Peers and S&P 500, Surges 42% YTD

Analyst Blog

Hasbro's (HAS) consistent efforts to establish a global presence via strategic partnerships and rapid growth emerging market bode well.

TTWO HAS ATVI MAT

Zacks Equity Research

Penn National Gaming Grows in Indiana's Sports Betting Space

Analyst Blog

Penn National Gaming (PENN) is likely to launch sports betting at Hollywood Casino Lawrenceburg this September.

LVS PENN BYD SCPL

Zacks Equity Research

Michaels Down 60% YTD: Can Growth Efforts Revive the Stock?

Analyst Blog

Michaels' (MIK) soft margin trend is likely to continue due to adverse impact of tariffs. Nevertheless, the company's efforts to enhance omni-channel experience are encouraging.

FOSL ULTA MIK BOOT

Zacks Equity Research

Nordstrom (JWN) Stock Rallies 12% on Earnings Beat in Q2

Analyst Blog

Nordstrom (JWN) posts better-than-expected earnings for second-quarter fiscal 2019, thanks to a decline in inventory and expenses.

FOSL GOOS JWN BOOT

Zacks Equity Research

Pure Storage (PSTG) Q2 Earnings & Revenues Beat Estimates

Analyst Blog

Pure Storage's (PSTG) robust adoption of FlashArray & FlashBlade solutions is driving growth.

PSTG FTNT CHGG AXE

Zacks Equity Research

Keysight (KEYS) Q3 Earnings & Revenues Surpass Estimates

Analyst Blog

Keysight's (KEYS) robust adoption driven by high demand for 5G design and test solutions along with strong pipeline for new business bookings are key catalysts.

FTNT CHGG KEYS AXE

Zacks Equity Research

PPG Industries to Display Teslin Label Solutions in Belgium

Analyst Blog

PPG Industries' (PPG) Teslin substrate is a secure, durable and easy-to-print synthetic material. It is ideal for applications that require high-performance, tough label solution.

PPG KGC AGI ARNC

Zacks Equity Research

FirstEnergy's (FE) Systematic Long-Term Investments Bode Well

Analyst Blog

FirstEnergy (FE) progresses with its modernization drive and Energizing the Future plan.

LNT IDA AES FE

Zacks Equity Research

Here's Why You Should Add IDACORP (IDA) to Your Portfolio

Analyst Blog

IDACORP (IDA) is poised to benefit from the ongoing increase in customer volumes, and systematic investments to strengthen and expand infrastructure.

IDA LNT NRG UTL

Zacks Equity Research

American Financial to Share More Profits, Hikes Dividend

Analyst Blog

American Financial's (AFG) recent 12.5% hike in dividend marks its intention to enhance shareholders value supported by strong financial position.

AIZ JRVR WRB AFG

Zacks Equity Research

Highwoods to Enter Charlotte, Exit Greensboro & Memphis

Analyst Blog

Highwoods Properties' (HIW) market rotation plan, which is in sync with enhancing BBD office focus, is likely to be accretive to cash flows.

HIW PLD EXR ARE

Zacks Equity Research

Company News for Aug 22, 2019

Corporate Summary

Companies In The News Are: HD, BA, MSFT, TSLA

BA TSLA HD MSFT

Sheraz Mian

Q2 Earnings Season Scorecard

Earnings Outlook

The Q2 earnings season is effectively over, with results from less than 5% of S&P 500 members still awaited, mostly from the Retail sector...

WMT TGT M JWN

David Borun

Spread Trade #8 - The Calendar

Know Your Options

Buying or selling a calendar spread is a bet on a divergence between actual and implied volatilities